COVID-19 — Coronavirus

Status
Not open for further replies.
purplenose said:
Why?

I think the bloke is OK and just because he has a business model that works unlike the likes of Virgin and BA he seems to be vilified.
Click to expand...

His constant bitching and moaning throughout this whole crisis and yes his business model 'works', but that doesn't make it ethically sound.
 
purplenose said:
Why?

I think the bloke is OK and just because he has a business model that works unlike the likes of Virgin and BA he seems to be vilified.
Click to expand...

Maybe so. But I think it would be fair to say there may be some conscious bias at play in him being against any form of restrictions on flights.
 
Manc in London said:
Any data or reports suggesting that treatment is improving/becoming more effective in the UK?
Click to expand...
Do a search on Heparin and Covid-19.
Standard practice to give more than required for 3 weeks or so now. A standard treatment in the UK for care of the elderly and long hospital stays.
This is regardless of what clinical guidelines have been given from on high.
 
BlueAnorak said:
Do a search on Heparin and Covid-19.
Standard practice to give more than required for 3 weeks or so now. A standard treatment in the UK for care of the elderly and long hospital stays.
This is regardless of what clinical guidelines have been given from on high.
Click to expand...

Can you or anyone translate the below into council speak for my benefit please? I have a feeling it looks positive but I have no idea what much of it means.


Results: There were 449 patients with severe COVID-19 enrolled into the study, 99 of them received heparin (mainly with low molecular weight heparin) for 7 days or longer. D-dimer, prothrombin time, and age were positively, and platelet count was negatively, correlated with 28-day mortality in multivariate analysis. No difference in 28-day mortality was found between heparin users and nonusers (30.3% vs 29.7%, P = .910). But the 28-day mortality of heparin users was lower than nonusers in patients with SIC score ≥4 (40.0% vs 64.2%, P = .029), or D-dimer >6-fold of upper limit of normal (32.8% vs 52.4%, P = .017).

Conclusions: Anticoagulant therapy mainly with low molecular weight heparin appears to be associated with better prognosis in severe COVID-19 patients meeting SIC criteria or with markedly elevated D-dimer.
 
ayrshire_blue said:
Can you or anyone translate the below into council speak for my benefit please? I have a feeling it looks positive but I have no idea what much of it means.


Results: There were 449 patients with severe COVID-19 enrolled into the study, 99 of them received heparin (mainly with low molecular weight heparin) for 7 days or longer. D-dimer, prothrombin time, and age were positively, and platelet count was negatively, correlated with 28-day mortality in multivariate analysis. No difference in 28-day mortality was found between heparin users and nonusers (30.3% vs 29.7%, P = .910). But the 28-day mortality of heparin users was lower than nonusers in patients with SIC score ≥4 (40.0% vs 64.2%, P = .029), or D-dimer >6-fold of upper limit of normal (32.8% vs 52.4%, P = .017).

Conclusions: Anticoagulant therapy mainly with low molecular weight heparin appears to be associated with better prognosis in severe COVID-19 patients meeting SIC criteria or with markedly elevated D-dimer.
Click to expand...

Its basically saying that the dippers will be crowned as champions
 
BlueAnorak said:
Do a search on Heparin and Covid-19.
Standard practice to give more than required for 3 weeks or so now. A standard treatment in the UK for care of the elderly and long hospital stays.
This is regardless of what clinical guidelines have been given from on high.
Click to expand...

Thanks for that.
 
Status
Not open for further replies.
Unread Posts

Don't have an account? Register now and see fewer ads!

SIGN UP
Back
Top
✖
  AdBlock Detected
Bluemoon relies on advertising to pay our hosting fees. Please support the site by disabling your ad blocking software to help keep the forum sustainable. Thanks.